back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-06 16:18 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-33,854 vol |
297,500 | |
| Filed 2025-07-03 11:31 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-03 11:26 Tx date 2024-07-18 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,662
+21,657 vol $0.40 each |
21,657 | |
| Filed 2025-07-03 11:23 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-03 11:22 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2025-07-03 10:22 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Carroll, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,999
+45,833 vol $0.48 each |
1,615,833 | |
| Filed 2024-07-18 13:54 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2025-07-02 17:18 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,500
+119,792 vol $0.48 each |
3,064,792 | |
| Filed 2025-07-02 17:12 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-02 17:10 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-02 17:08 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Fradette, Glenn Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+68,750 vol $0.48 each |
673,750 | |
| Filed 2025-07-02 17:06 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Tatchell, Terri Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,500
+88,542 vol $0.48 each |
454,965 | |
| Filed 2025-07-02 17:04 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,249
+33,854 vol $0.48 each |
331,354 | |
| Filed 2025-07-02 17:02 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
LeRoux, Calvin Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,499
+67,708 vol $0.48 each |
434,131 | |
| Filed 2025-07-02 17:00 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$62,499
+130,208 vol $0.48 each |
830,138 | |
| Filed 2024-09-05 19:44 Tx date 2024-08-27 |
$PCRX
PharmaCorp Rx Inc. |
Amy, Krista Michelle
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: 102031365 Saskatchewan Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
910,025 | ||
| Filed 2024-09-05 19:39 Tx date 2024-08-27 |
$PCRX
PharmaCorp Rx Inc. |
Amy, Krista Michelle
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
62,500 |